MarketPulse — Real-Time Financial News & Market Analysis

Oral weight-loss drugs expand the market rather than cannibalizing injectables, attracting new patients. However, Novo Nordisk expects 2026 revenue headwinds from competition and pricing pressures.

TransAlta shares surged 29% over twelve months. Major fund Potrero Capital trimmed its stake through strategic rebalancing, though maintains confidence in the power company.

Integer Holdings stock rose 2% after Q4 earnings beat expectations and analyst upgrades. Multiple firms raised price targets, citing strong sales growth and improved profit margins.

Potrero Capital invests $20.5M in BlackLine, betting on the financial software company's turnaround despite recent stock declines, citing margin expansion and positive guidance.

Vistagen investors face March 16, 2026 deadline in securities lawsuit alleging false statements about drug trials and clinical data that misled shareholders.

uniQure faces securities class action over allegedly misleading FDA approval claims and timeline delays. Investors must act before April 13, 2026 deadline.

Breach Inlet Capital acquires $9.8M stake in Frontdoor amid 14% revenue growth and 64% free cash flow surge, betting stock has been undervalued.

Opendoor shares rose 7.42% on Q4 results showing 46% purchase growth and reduced costs, signaling progress toward 2026 profitability targets.

Palo Alto Networks shares fell 1.5% after Anthropic launched Claude Code Security, an AI tool for identifying code vulnerabilities, raising concerns about disruption to traditional cybersecurity vendors.

Rosen Law Firm investigates Lufax for potential securities violations after the fintech company removed auditors and delayed its annual report, causing stock to plunge 13.8%.

Class action lawsuit filed against REGENXBIO for allegedly making false statements about gene therapy safety and efficacy while withholding adverse trial information from investors.

Tech giants plan $700B AI infrastructure spending. Chip suppliers like Broadcom and Micron positioned to benefit from demand for networking and memory components.

Distributech shares fell 19% after missing earnings expectations despite doubling revenue from MRC Global acquisition. Integration challenges with legacy systems raised investor concerns about synergy timelines.

Kirby McInerney LLP filed securities fraud lawsuit against Kyndryl Holdings for alleged financial misstatements and inadequate internal controls. Stock plummeted 55% after SEC scrutiny.

NuScale Power faces class action lawsuit alleging false statements about partner ENTRA1's qualifications. Stock declined 12% after disclosing $495M payment and $532M quarterly loss.

Hub Group restated 2025 financials after discovering material accounting errors in transportation costs and payables. Stock fell 18.3%, triggering shareholder lawsuits over disclosure adequacy.

Law firm investigates Cogent Communications for potential securities violations following 6% revenue decline and 98% dividend cut that tanked stock 35%.

Paysafe investors face April 7, 2026 deadline to join securities fraud class action over allegedly misleading statements about business operations and financial guidance.

Psyence BioMed issues $5M in shares to PsyLabs via put option exercise, giving PsyLabs ~50% ownership and strengthening supply chain for psychedelic pharmaceuticals.

Constellation Software moved its Q4 earnings call to March 9 at 8:30 a.m. EST, one day earlier than originally scheduled, with financial results releasing at 7:00 a.m. that day.